Stock listing
NASDAQ:ATXS Astria Therapeutics Inc Stock
Follow Astria Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ATXS
$12.50 USD
Close on Jan 21, 2026 · No longer trades
- Lowest – highest close
- $2.46 – $16.69 USDSince Aug 20, 2021 · lowest Jun 16, 2022 · highest Mar 19, 2024
Delisted NASDAQ:ATXS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ATXS
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Astria Therapeutics Inc on 6ix
- Calls
- 2 calls with a replay · 2 with a transcript · latest Nov 13, 2023
- Decks
- 12 decks · latest Oct 14, 2025
Where Astria Therapeutics Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ATXS · This page · Delisted | NASDAQ | United States | USD |
| NASDAQ:CATB · Delisted | NASDAQ | United States | USD |
Events
| Call | When | Status |
|---|---|---|
| Astria Therapeutics (ATXS) Q3 2023 Earnings Call | Mon, Nov 13, 2023 · 8:30 AM ET | Replay |
| Astria Therapeutics (ATXS) Q3 2021 Earnings Call | Wed, Nov 10, 2021 · 8:30 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (October 2025) | Merger or acquisition | 14 slides | Oct 14, 2025 |
| Merger or Acquisition (October 2025) | Merger or acquisition | 11 slides | Oct 14, 2025 |
| Investor Presentation (January 2025) | Investor deck | 38 slides | Jan 13, 2025 |
| Investor Presentation (October 2023) | Investor deck | 28 slides | Oct 11, 2023 |
| Investor Presentation (January 2023) | Investor deck | 19 slides | Jan 5, 2023 |
| Technical Presentation (December 2022) | Technical | 30 slides | Dec 15, 2022 |
| Investor Presentation (September 2021) | Investor deck | 21 slides | Sep 8, 2021 |
| Catabasis Pharmaceuticals — Investor Presentation (June 2021) | Investor deck | 19 slides | Jun 2, 2021 |
| Catabasis Pharmaceuticals — Merger or Acquisition (January 2021) | Merger or acquisition | 21 slides | Jan 29, 2021 |
| Catabasis Pharmaceuticals — Investor Presentation (December 2017) | Investor deck | 35 slides | Dec 11, 2017 |
All 12 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Catabasis Pharmaceuticals — Corporate Update (October 2017) | Corporate update | 28 slides | Oct 4, 2017 |
| Catabasis Pharmaceuticals — Corporate Update (June 2017) | Corporate update | 28 slides | Jun 19, 2017 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Kenneth Bate Other companies: Madrigal Pharmaceuticals, Inc. (Director · Since at least Jul 22, 2016); Vanda Pharmaceuticals Inc. (Director · Dec 17, 2015 – Jun 15, 2017 · Past); Epizyme Inc (Director · Dec 10, 2014 – Aug 12, 2022 · Past); BioMarin Pharmaceutical Inc. (Director · Sep 22, 2010 – Jun 10, 2015 · Past); AVEO Pharmaceuticals Inc (Director · Mar 11, 2010 – Jan 19, 2023 · Past); Coley Pharmaceutical Group Inc (Director · Jun 21, 2006 – Jan 4, 2008 · Past); Cubist Pharmaceuticals Inc (Director · Jun 8, 2006 – Jan 21, 2015 · Past); Nitromed Inc (President & CEO, Director · Mar 20, 2006 – Apr 24, 2009 · Past) | Director · Since at least Jun 24, 2015 |
| Jean George Other companies: Cyteir Therapeutics Inc (Director · Jun 17, 2021 – Feb 14, 2024 · Past); Disc Medicine, Inc. (Director · Feb 5, 2021 – Feb 5, 2021 · Past); Calithera Biosciences, Inc. (Director · Oct 1, 2014 – Jun 11, 2021 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Jan 22, 2020 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – May 28, 2013 · Past); Zeltiq Aesthetics Inc (Director · Oct 18, 2011 – Jul 22, 2015 · Past) | Director · Jun 24, 2015 – Jun 7, 2018 · Past |
| Sunil Agarwal Other companies: Arvinas, Inc. (Director · Since at least Jun 15, 2023); Sana Biotechnology, Inc. (EVP, Head of Development & CMO · Feb 3, 2021 – Mar 3, 2022 · Past); Juno Therapeutics Inc (President of R & D · Apr 13, 2017 – Mar 5, 2018 · Past); MyoKardia Inc (Director · Mar 4, 2016 – Nov 17, 2020 · Past); Calithera Biosciences, Inc. (Director · Sep 29, 2015 – Jun 1, 2022 · Past); Ultragenyx Pharmaceutical Inc. (Chief Medical Officer · Aug 19, 2015 – Aug 19, 2016 · Past) | Director · Since at least Apr 5, 2024 |
| Anthony Gregg Lapointe Other companies: Rigel Pharmaceuticals, Inc. (Director · Since at least Oct 31, 2017); Soligenix, Inc. (Director · Since at least Mar 10, 2009); Raptor Pharmaceutical Corp (Director · Jan 1, 2015 – Oct 24, 2016 · Past); Questcor Pharmaceuticals Inc (Director · Oct 9, 2009 – Jan 1, 2010 · Past); SciClone Pharmaceuticals Inc (Director · Mar 30, 2009 – Oct 13, 2017 · Past) | Director · Since at least Jan 3, 2019 |
| Fred Callori Other companies: LeonaBio, Inc. (Director · Since at least May 5, 2026); Landos Biopharma Inc (Director · Aug 27, 2021 – May 23, 2024 · Past) | Director · Since at least Jan 28, 2021 |
| Hugh M Cole Other companies: Jounce Therapeutics Inc (Chief Operating Officer · Dec 20, 2017 – Jan 9, 2023 · Past); Ariad Pharmaceuticals Inc (SVP, Chief Business Officer · Apr 29, 2016 – Feb 16, 2017 · Past) | Director · Since at least Jul 26, 2019 |
| Michael D Kishbauch Other companies: Progenics Pharmaceuticals Inc (Director · Jun 8, 2016 – Jul 11, 2019 · Past); Achillion Pharmaceuticals Inc (Director · Jan 25, 2016 – Jan 28, 2020 · Past) | Director · Since at least Apr 5, 2016 |
| Christopher Morabito Other companies: Fulcrum Therapeutics, Inc. (Chief Medical Officer · May 10, 2021 – Jan 19, 2022 · Past) | Chief Medical Officer · Since at least Jul 14, 2022 |
| Jill Milne Other companies: BioCryst Pharmaceuticals, Inc. (Director · Since at least Jan 23, 2026) | CEO and President, Director · Since at least Jun 24, 2015 |
| Joanne M. Donovan Other companies: Edgewise Therapeutics, Inc. (Chief Medical Officer · Since at least Apr 26, 2021) | CMO; SVP Clinical Development · Jun 24, 2015 – Feb 12, 2020 · Past |
All 18 people
| Person | Seat |
|---|---|
| Joanne T Beck Other companies: Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past) | Director · Since at least Feb 13, 2019 |
| Rick Modi Other companies: AveXis Inc (Chief Business Officer · Feb 13, 2017 – May 15, 2018 · Past) | Chief Business Officer · Jun 24, 2015 – Sep 8, 2016 · Past |
| Andrea Matthews | Chief Business Officer · Since at least Apr 17, 2023 |
| Benjamin Harshbarger | Chief Legal Officer · Since at least Jun 2, 2023 |
| Edward K Hibben | Chief Business Officer · Feb 8, 2018 – Feb 8, 2018 · Past |
| Ian C Sanderson | Chief Financial Officer · Feb 11, 2016 – Feb 11, 2016 · Past |
| Michael Jirousek | Chief Scientific Officer · Jun 24, 2015 – Jun 30, 2015 · Past |
| Ron Laufer | Director · Jun 24, 2015 – Jun 30, 2015 · Past |
Log in to ask 6ix AI your own questions about Astria Therapeutics Inc.